UBS ASSET MANAGEMENT AMERICAS INC - EIDOS THERAPEUTICS INC ownership

EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 123 filers reported holding EIDOS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.50 and the average weighting 0.6%.

Quarter-by-quarter ownership
UBS ASSET MANAGEMENT AMERICAS INC ownership history of EIDOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$1,849,620,000
+291.2%
14,057
+50.2%
0.00%
Q3 2020$472,809,000
+136.2%
9,357
+122.8%
0.00%
Q2 2020$200,214,000
+8597.4%
4,200
+6462.5%
0.00%
Q3 2019$2,302,000
+15.7%
640.0%0.00%
Q2 2019$1,989,000640.00%
Other shareholders
EIDOS THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Aisling Capital Management LP 1,123,630$147,847,00025.39%
Affinity Asset Advisors, LLC 225,000$29,606,00015.69%
Chicago Capital Management, LLC 79,922$10,516,0008.38%
Opaleye Management Inc. 315,550$41,520,0005.42%
Board of Trustees of The Leland Stanford Junior University 265,670$34,957,0002.46%
Kellner Capital, LLC 26,357$3,468,0001.83%
SPRING CREEK CAPITAL LLC 140,000$18,421,0001.35%
AQR Arbitrage LLC 274,853$36,165,0001.27%
Magnetar Financial LLC 599,330$78,860,0001.11%
ALPINE ASSOCIATES MANAGEMENT INC. 184,221$24,240,0000.99%
View complete list of EIDOS THERAPEUTICS INC shareholders